Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

RecA inactivation as a strategy to reverse the heteroresistance phenomenon in clinical isolates of Escherichia coli

  • Díaz-Díaz, Sara
  • Yerbes, Pilar
  • Recacha, Esther
  • Gregorio-Iaria, Belén de
  • Pulido, Marina R.
  • Romero-Muñoz, María
  • Docobo-Pérez, Fernando
  • Pascual, Álvaro
  • Rodríguez-Martínez, José-Manuel
RecA inhibition could be an important strategy to combat antimicrobial resistance because of its key role in the SOS response, DNA repair and homologous recombination contributing to bacterial survival. This study evaluated the impact of RecA inactivation on heteroresistance in clinical isolates of Escherichia coli and their corresponding recA-deficient isogenic strains to multiple classes of antimicrobial agents. A high frequency (>30%) of heteroresistance was observed in this collection of clinical isolates. Deletion of the recA gene led to a marked reduction in heteroresistant subpopulations, especially against quinolones or β-lactams. The molecular basis of heteroresistance was associated with an increase in copy number of plasmid-borne resistance genes (blaTEM-1B) or tandem gene amplifications (qnrA1). Of note, in the absence of the recA gene, the increase in copy number of resistance genes was suppressed. This makes the recA gene a promising target for combating heteroresistance., This work was supported by the Plan Nacional de I+D+i 2013–2016 and the Instituto de Salud Carlos III [projects PI17/01501 and PI20/00239], Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI) [RD16/0016/0001 and RD16/0016/0009]—co‐financed by European Development Regional Fund ‘A way to achieve Europe’, Operative program Intelligent Growth 2014–2020. SD-D is supported by a PFIS grant from the Instituto de Salud Carlos III [FI18/00086], co-funded by ESF ‘Investing in your future’. ER is supported by a Juan Rodés Grant from the Instituto de Salud Carlos III [JR21/00030], co-funded by ESF ‘Investing in your future’. MRP is supported by a VIPPI-US fellowship from the University of Seville. MR-M is supported by the Fondo Social Europeo [EJ5-91, Programa Iniciativa de Empleo Juvenil]., Peer reviewed